Cell therapy trial for infection-related septic shock in ICU
Part of Infections clinical trials.
This Phase 2 trial tests an immune-boosting cell therapy (umbilical mesenchymal stromal cells) in people with septic shock—when infection causes dangerous stress on the heart and other organs. The goal is to see if this treatment can improve outcomes compared with standard care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older
- You are in the ICU for the first time for this illness
- Your heart/blood pressure failure from infection has lasted at least 1 hour and needs strong blood-pressure medicine
- Within about a day, you also have at least one other new serious organ problem (lungs, blood, kidneys, or poor circulation measured by lactate)
- A clinician believes the shock is caused by infection
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a treatment made from human umbilical cord cells to help the body fight severe infections (sepsis). It might reduce inflammation and improve recovery.
This trial tests a new treatment to protect and repair the layer of cells lining your blood vessels (glycocalyx) during sepsis. It aims to improve recovery from severe infections.
This study looks at how special cells from bone marrow (called stem cells) might help fix immune problems caused by sepsis. The goal is to see if these cells can improve how your immune system works during a severe infection.
This trial looks at how the immune system changes after septic shock in adults in the ICU. It may help doctors better predict or manage complications by studying blood markers a few days after starting treatment.
This trial tests a new approach to treating septic shock, a life-threatening condition where infection causes dangerously low blood pressure. It aims to see if a different way of managing fluids and medications can improve recovery compared to standard care.
This trial tests a special blood-filtering method (adaptive blood purification) for people with septic shock caused by a severe infection. It aims to see if this treatment can help control inflammation and improve recovery in the ICU.
Hear when a new Septic Shock trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.